Adage Capital Partners
KYTH

Adage Capital Partners’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Adage Capital Partners’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-65,000
Closed -$4.87M – 791
2015
Q3 		$4.87M Buy
+65,000
New +$4.85M 0.01% 617
2015
Q1 		– Sell
-587,226
Closed -$20.4M – 801
2014
Q4 		$20.4M Sell
587,226
-112,774
-16% -$3.94M 0.05% 404
2014
Q3 		$22.9M Hold
700,000
– – 0.06% 362
2014
Q2 		$26.9M Sell
700,000
-94,200
-12% -$3.29M 0.07% 327
2014
Q1 		$31.6M Sell
794,200
-274,200
-26% -$12.3M 0.09% 282
2013
Q4 		$39.9M Buy
1,068,400
+568,400
+114% +$23.6M 0.11% 252
2013
Q3 		$22.8M Buy
500,000
+75,000
+18% +$2.24M 0.07% 346
2013
Q2 		$11.5M Buy
+425,000
New +$9.73M 0.04% 472

Adage Capital Partners's KYTH Position: Q4 2015 in Review

Adage Capital Partners sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 65,000 shares — an estimated $4.87M sold.

Adage Capital Partners first reported a position in KYTH in Q2 2013 and held it in 8 quarters. The position peaked at $39.9M in Q4 2013. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Adage Capital Partners reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Adage Capital Partners sold 65,000 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $4.87M.
  • Adage Capital Partners first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 8 quarters.
  • Adage Capital Partners's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $39.9M in Q4 2013.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Adage Capital Partners's 13F filing for Q4 2015, filed 16 Feb 2016.